128 results
Page 2 of 7
424B5
xnzn0n67qpwqcnv53u
21 Apr 23
Prospectus supplement for primary offering
5:14pm
S-8
EX-5.1
hhmd5
22 Dec 22
Registration of securities for employees
5:37pm
8-K
EX-99.2
mjzu0zs6we71rfl473
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.5
n0e0s37r7auzw61m1
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-10.6
n3cl27 w28
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.4
88zep7 asa
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
EX-99.6
isxp29jmg
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
8-K
q423sw4fvxcl3 n9to
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
425
m3opemli4tm8
5 Dec 22
Business combination disclosure
9:28am
8-K
EX-10.1
blwy1ax
5 Dec 22
Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger with Kineta
9:27am
424B3
3kscldu2w4
5 Dec 22
Prospectus supplement
9:22am
425
38mb6wyg5
14 Nov 22
Business combination disclosure
8:50am
8-K
EX-99.2
dtzp5u98t9 4y7
14 Nov 22
Yumanity Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
8:37am
424B3
azaop ce0
10 Nov 22
Prospectus supplement
4:21pm